Screening for SARS-COV-2 infection in pediatric oncology patients during
the epidemic peak in Italy
AbstractSARS-COV-2 infection can be asymptomatic or mildly symptomatic. The
effect of chemotherapy on an asymptomatic infected patient is unknown.
Three hundred-thirty-four and 56 NFS were performed as screening for
SARS-CoV-2 infection in 247 and 34 pediatric patients undergoing
chemotherapy and stem cell transplantation, respectively. NFS was
positive in 10 patients. All positive patients withdrew from
chemotherapy. Nine patients became negative. One patient is still
positive after 38 days.The identification of asymptomatic SARS-COV-2
infection is important to reduce the hospital spread of infection.
Further studies are needed to define the least risky management of
chemotherapy in asymptomatic SARS-CoV-2 patients.